Techniques For Increasing Solubility: A Review Of Conventional And New Strategies

Authors

  • Keerti Yadav Department of Pharmaceutics, Dayanand Dinanath College Institute of Pharmacy, Kanpur Uttar Pradesh, India.
  • Anupam Kr. Sachan Associate Professor, Department of Pharmaceutics, Dayanand Dinanath College Institute of Pharmacy, Kanpur Uttar Pradesh, India.
  • Sunil Kumar Assistant Professor, Department of Pharmaceutics, Dayanand Dinanath College Institute of Pharmacy, Kanpur Uttar Pradesh, India.
  • Anubhav Dubey Assistant Professor, Department of Pharmacy, Maharana Pratap College of Pharmacy, Kanpur Uttar Pradesh, India

DOI:

https://doi.org/10.22270/ajprd.v10i2.1054

Keywords:

Solubility, Critical factor, Bioavailability, Complexation, Dissolution.

Abstract

Whenever a drug's success depends on its ability to disperse evenly in the liquid phase, solubility is a critical factor. Most active pharmacological compounds, on the other hand, are poorly soluble in water. The solubility of the medications is one of the most difficult parts of formulation creation. Due to a lack of water solubility, critical ingredients are left out of final medications, preventing them from reaching their full therapeutic potential. Due to poor water solubility, many novel medicines fail to launch in the market, despite their promising pharmacokinetic properties. Solubility in water limits the potential bioavailability of molecules that would otherwise have a significant impact on their physiological target. To achieve the desired (anticipat5ed) pharmacological response in the systemic circulation, aqueous solubility of a drug also affects the physical, chemical, dose stability, severs as a standard for purity, dissolution rate, rate and extent of absorption, and achieves the desired concentration of the drug in systemic circulation. When it comes to the formulation of medications, solubility is an extremely essential issue. A new API with high market demand must be developed by the formulation scientist if the molecule is to make it through the pharmaceutical development process. Solubilization techniques, such as chemical modification using solubilizers such as soluplus, povacoat, and dendrimers, as well as physical modification, complexation, and the use of surfactant, are being discussed in this review article because they are becoming increasingly important to the pharmaceutical industry by opening up new pathways for the preparation of effective and marketable drugs.

 

Downloads

Download data is not yet available.

Author Biographies

Keerti Yadav, Department of Pharmaceutics, Dayanand Dinanath College Institute of Pharmacy, Kanpur Uttar Pradesh, India.

Department of Pharmaceutics, Dayanand Dinanath College Institute of Pharmacy, Kanpur Uttar Pradesh, India.

Anupam Kr. Sachan, Associate Professor, Department of Pharmaceutics, Dayanand Dinanath College Institute of Pharmacy, Kanpur Uttar Pradesh, India.

Associate Professor, Department of Pharmaceutics, Dayanand Dinanath College Institute of Pharmacy, Kanpur Uttar Pradesh, India.

Sunil Kumar, Assistant Professor, Department of Pharmaceutics, Dayanand Dinanath College Institute of Pharmacy, Kanpur Uttar Pradesh, India.

Assistant Professor, Department of Pharmaceutics, Dayanand Dinanath College Institute of Pharmacy, Kanpur Uttar Pradesh, India.

Anubhav Dubey, Assistant Professor, Department of Pharmacy, Maharana Pratap College of Pharmacy, Kanpur Uttar Pradesh, India

Assistant Professor, Department of Pharmacy, Maharana Pratap College of Pharmacy, Kanpur Uttar Pradesh, India

References

1. Awuchi, C. G., Amagwula, I. O., Priya, P., Kumar, R., Yezdani, U., & Khan, M. G. (2020). Aflatoxins in foods and feeds: A review on health implications, detection, and control. Bull Environ Pharmacol Life Sci, 2020; 9(9):149-155.
2. Akhgari A, Shakib Z, Sanati S, A review on electrospun nanofibers for oral drug delivery. Nanomedicine Journal 2017; 4:197–207.
3. Alldredge BK, Corelli RL, Ernst ME, Guglielmo BJ, Jacobson PA, Kradjan WA, Williams BR (2013) Koda-kimble and Young’s applied therapeutics: the clinical use of drugs. Wolters Kluwer Health Adis (ESP).
4. Alubaidy A, Venkatakrishnan K, Tan B, Nanofibers reinforced polymer composite microstructures. Adv Nanofiber 2013;7:165–184. https://doi.org/10.5772/57101
5. Bhanja S, Ellaiah P, Martha S, Sahu A, Padhy S, Preparation and evaluation of solid dispersions of poorly soluble drug repaglinide. Asian Journal of Biochemical and Pharmaceutical Research 2011; 3:201–221.
6. Bindhani S, Mohapatra S ,Recent approaches of solid dispersion: a new concept toward oral bioavailability. Asian Journal of Pharmaceutical and Clinical Research 2018; 11:72–78. https://doi.org/10.22159/ajpcr.2018.v11i2.23161
7. Broadhead J, Edmond Rouan S, Rhodes C, The spray drying of pharmaceuticals. Drug development and industrial pharmacy 1992; 18: 1169–1206. https://doi.org/10.3109/03639049209046327
8. Buckton G, Beezer AE (1992) The relationship between particle size and solubility. International journal of pharmaceutics 1992; 82:R7–R10. https://doi.org/10.1016/0378-5173(92)90184-4
9. Sahana, S. Purabi saha, Roshan kumar, Pradipta das, Indranil Chatterjee, Prasit Roy, Sk Abdur Rahamat. A Review of the 2019 Corona virus (COVID-19) World Journal of Pharmacy and Pharmaceutical science, 2020; 9(9):2367-2381.
10. Chavan RB, Thipparaboina R, Kumar D, Shastri NR, Co amorphous systems: A product development perspective. International journal of pharmaceutics 2016; 515:403–415. https://doi.org/10.1016/j.ijpharm.2016.10.043
11. Chiou WL, Riegelman S (1971) Pharmaceutical applications of solid dispersion systems. Journal of pharmaceutical sciences 1971; 60:1281–1302. https://doi.org/10.1002/jps.2600600902
12. Davis ME, Brewster ME, Cyclodextrin-based pharmaceutics: past, present and future. Nature reviews Drug discovery 2004; 3:1023–1035. https://doi.org/10.1038/nrd1576
13. Dengale SJ, Grohganz H, Rades T, Löbmann K, Recent advances in co-amorphous drug formulations. Advanced drug delivery reviews 2016; 100:116–125. https://doi.org/10.1016/j.addr.2015.12.009
14. Bind, A., Das, S., Singh, V. D., Kumar, R., Chourasia, A., & Saha, P. Natural Bioactives For The Potential Management Of Gastric Ulceration. Turkish Journal of Physiotherapy and Rehabilitation, 32, 3.
15. Duong AD, Ruan G, Mahajan K, Winter JO, Wyslouzil BE, Scalable, semicontinuous production of micelles encapsulating nanoparticles via electrospray. Langmuir 2014; 30: 3939–3948. https://doi.org/10.1021/la404679r
16. El-Nabarawi M, Khalil I, Saad R, Impact of hydrophilic polymer solubilization on bioavailability enhancement of repaglinide by solid dispersion. Inven Rapid Pharm Tech 2016; 3:1–12.
17. Gadadare R, Mandpe L, Pokharkar V, Ultra rapidly dissolving repaglinide nanosized crystals prepared via bottom-up and top-down approach: influence of food on pharmacokinetics behavior. AAPS Pharm SciTech 2015; 16:787–799. https://doi.org/10.1208/s12249-014-0267-8
18. Kumar, S., Kumar, A., Kumar, R., Kumar, V., Kumar, N., & Tyagi, A. Phytochemical, Pharmacognostical and Pharmacological Activities of Carica papaya. International Journal for Research in Applied Sciences and Biotechnology, 2022; 9(2):310-315.
19. Goonoo N, Bhaw-Luximon A, Jhurry D, Drug loading and release from electrospun biodegradable nanofibers. Journal of biomedical nanotechnology 2014; 10:2173–2199. https://doi.org/10.1166/jbn.2014.1885
20. Guardado-Mendoza R, Prioletta A, Jiménez-Ceja LM, Sosale A, Folli F (2013) The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus. Archives of medical science: AMS 9: e936. https://doi.org/10.5114/aoms.2013.34991
21. Guo B, Liu H, Li Y, Zhao J, Yang D, Wang X, Zhang T (2014) Application of phospholipid complex technique to improve the dissolution and pharmacokinetic of probucol by solvent-evaporation and co-grinding methods. International journal of pharmaceutics 2014; 474:50–56. https://doi.org/10.1016/j.ijpharm.2014.08.006
22. Gupte M, Ma P, Nanofibrous scaffolds for dental and craniofacial applications. Journal of dental research 2012; 91:227–234. https://doi.org/10.1177/0022034511417441
23. Hartgerink JD, Beniash E, Stupp SI, Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 2001; 294:1684–1688. https://doi.org/10.1126/science.1063187
24. Hatorp V, Clinical pharmacokinetics and pharmacodynamics of repaglinide. Clinical pharmacokinetics 2002; 41:471–483. https://doi.org/10.2165/00003088-200241070-00002
25. Huang M, Hou Y, Li Y, Wang D, Zhang L, High performances of dual network PVA hydrogel modified by PVP using borax as the structure-forming accelerator. Designed monomers and polymers2017; 20:505–513. https://doi.org/10.1080/15685551.2017.1382433
26. Kabanov AV, Batrakova EV, Alakhov VY, Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. Journal of controlled release2002; 82:189–212. https://doi.org/10.1016/S0168-3659(02)00009-3
27. Karagianni A, Kachrimanis K, Nikolakakis I, Co-amorphous solid dispersions for solubility and absorption improvement of drugs: Composition, preparation, characterization and formulations for oral delivery. Pharmaceutics 2018; 10: e98. https://doi.org/10.3390/pharmaceutics10030098
28. Kumar, S., Kumar, A., Kumar, R., Kumar, V., Kumar, N., & Tyagi, A. Phytochemical, Pharmacognostical and Pharmacological Activities of Carica papaya. International Journal for Research in Applied Sciences and Biotechnology, 2022; 9(2):310-315.
29. Kassem AA, Abd El-Alim SH, Basha M, Salama A (2017) Phospholipid complex enriched micelles: a novel drug delivery approach for promoting the antidiabetic effect of repaglinide. European journal of pharmaceutical sciences 2017; 99:75–84. https://doi.org/10.1016/j.ejps.2016.12.005
30. Kaushal AM, Gupta P, Bansal AK (2004) Amorphous drug delivery systems: molecular aspects, design, and performance. Critical Reviews in Therapeutic Drug Carrier Systems 21. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v21.i3.10
31. Khadka P, Ro J, Kim H, Kim I, Kim JT, Kim H, Cho JM, Yun G, Lee J (2014) Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability. Asian journal of pharmaceutical sciences 2014; 9:304–316. https://doi.org/10.1016/j.ajps.2014.05.005
32. Khajavi R, Abbasipour M, Electrospinning as a versatile method for fabricating coreshell, hollow and porous nanofibers. Scientia Iranica 2012; 19:2029–2034. https://doi.org/10.1016/j.scient.2012.10.037
33. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J (2020) Epidemiology of type 2 diabetes–global burden of disease and forecasted trends. Journal of epidemiology and global health 10: e107. https://doi.org/10.2991/jegh.k.191028.001
34. Dubey, A., Yadav, P., Verma, P., & Kumar, R. Investigation of Proapoptotic Potential of Ipomoea carnea Leaf Extract on Breast Cancer Cell Line. Journal of Drug Delivery and Therapeutics, 2022; 12(1):51-55.
35. La SB, Okano T, Kataoka K, Preparation and characterization of the micelle‐forming polymeric drug indomethacin‐incorporated poly (ethylene oxide)–poly (β‐benzyl L‐aspartate) block copolymer micelles. Journal of pharmaceutical sciences 1996; 85:85–90. https://doi.org/10.1021/js950204r
36. Laitinen R, Lobmann K, Grohganz H, Strachan C, Rades T, Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability. Molecular pharmaceutics 2014; 11:2381–2389. https://doi.org/10.1021/mp500107s
37. Lakshmi P, Kumar GA (2010) Nanosuspension technology: A review. Int J Pharm Sci 2: 35–40.
38. Loftsson T,Drug solubilization by complexation. International journal of pharmaceutics 2017; 531:276–280. https://doi.org/10.1016/j.ijpharm.2017.08.087
39. Lu Y, Li Y, Wu W, Injected nanocrystals for targeted drug delivery. Acta Pharmaceutica Sinica B 2016; 6:106–113. https://doi.org/10.1016/j.apsb.2015.11.005
40. Dubey, A., Yadav, P., Verma, P., & Kumar, R. Investigation of Proapoptotic Potential of Ipomoea carnea Leaf Extract on Breast Cancer Cell Line. Journal of Drug Delivery and Therapeutics, 2022; 12(1):51-55.
41. Mandić Z, Gabelica V. Ionization, lipophilicity and solubility properties of repaglinide. Journal of pharmaceutical and biomedical analysis 2006; 41:866–871. https://doi.org/10.1016/j.jpba.2006.01.056
42. Mata J, Majhi P, Guo C, Liu H, Bahadur P.Concentration, temperature, and salt-induced micellization of a triblock copolymer Pluronic L64 in aqueous media. Journal of colloid and interface science 2005; 292:548–556. https://doi.org/10.1016/j.jcis.2005.06.013
43. Mogal S, Gurjar P, Yamgar D, Kamod A. Solid dispersion technique for improving solubility of some poorly soluble drugs. Der Pharmacia Lettre 2012; 4:1574–1586.
44. Möschwitzer JP, Drug nanocrystals in the commercial pharmaceutical development process. International journal of pharmaceutics 2013; 453:142–156. https://doi.org/10.1016/j.ijpharm.2012.09.034

Published

2022-05-16

How to Cite

Yadav, K., Sachan, A. K., Kumar, S., & Dubey, A. (2022). Techniques For Increasing Solubility: A Review Of Conventional And New Strategies. Asian Journal of Pharmaceutical Research and Development, 10(2), 144–153. https://doi.org/10.22270/ajprd.v10i2.1054